Vetter News

CDMO Insights
Clinical manufacturing on time and within budget

The key to successful development and guiding a drug to approval is early planning.

Read more

CDMO Insights
ID determination of oligonucleotides

Fast, safe and efficient: the new Vetter ID determination of oligonucleotides.

Read more

CDMO Insights
Vetter’s strategic growth in APAC

Interview with Oskar Gold, SVP Asia Pacific and Global Emerging Markets

Read more

CDMO Insights
Injectable Drug Delivery Trends

How medication trends are driving the shift to patient-friendly drug delivery systems.

Read more

CDMO Insights
Challenges of variations in tub packaging

Why double-bagged tubs are an issue for high-speed filling lines

Read more

CDMO Insights
Digitalization in the pharmaceutical industry

A CDMO’s Guide to Digitalization in the Pharmaceutical Industry

Read more

CDMO Insights
Vetter Cleanroom Technology (V-CRT®)

A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility

Read more

CDMO Insights
CDMOs’ evolving role in drug development

Why CDMOs are increasingly vital to successful drug development

Read more

CDMO Insights
Technology transfer

All technology transfers are high-risk. An experienced CDMO partner is critical in this challenging process.

Read more

CDMO Insights
Small Scale Batch Manufacturing

How small production quantities are growing in importance

Read more

CDMO Insights
5 key factors in successful secondary packaging strategy

Five key considerations we share with companies who are deciding where and when to make key decisions about their secondary packaging strategy.

Read more

CDMO Insights
Cartridge filling: Understanding the complexities

For companies looking to gain a competitive edge, pen injectors and cartridges offer an attractive solution.

Read more